Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark Remedies

Group Health Research Editor Shares Toolkit To Boost Health Literacy
The doctor"s mouth opens, and "medicalese" pours forth: words like "pyrosis" and "myocardial infarction." The patient"s eyes glaze over. If only the doctor said "heartburn" or "heart attack," the patient could learn what caused the chest pain.
generic viagra online
IOM Report Calls For Big Boost In Global Health
To fulfill America"s humanitarian obligations as a member of the international community and to invest in the nation"s long-term health, economic interests, and national security, the United States should reaffirm and increase its commitment to improving the health of developing nations, says a new report from the Institute of Medicine.
News of the day
East Texas Health Organization Sees Increase In HIV Cases
Officials at an East Texas health care organization, Health Horizons, which provides HIV testing and other services to people in 12 counties, "has seen more East Texans test positive for [HIV] so far this year than it did for all of 2008," the Lufkin Daily News reports. Executive Director Wilbert Brown said, "We"ve had eight people out of more than 800 test positive for HIV in the first seven months of this year. Most of those have been African-American men. Last year we had a total of six out of more than 1,000. I expect us to see two or three more positives before the year is out. The state average for testing positive is one in 100, and we"re getting close to that number." According to the article, "Brown said he attributes the increase to Health Horizon"s aggressive outreach program targeting high-risk groups and to people realizing the importance of getting tested." The Daily News article also profiles a client of Health Horizons (Cooley, 8/2)
Diagnostics

PinPointe™ FootLaser™ Submits Its Breakthrough Laser Treatment For Toenail Fungus To Health Canada For Approval

PinPointe FootLaser announced it has submitted its innovative new laser treatment for toenail fungus (Onychomycosis) to Health Canada for approval. As the Federal department responsible for helping Canadians maintain and improve their health, Health Canada reviews medical devices to assess their safety, effectiveness and quality before being authorized for sale in Canada. PinPointe FootLaser has been awarded the CE Mark certifying it has met European Union consumer health and safety standards, has been cleared for use in the treatment of toenail fungus in the EU, and can be offered by healthcare providers throughout Europe. Additionally, the treatment is FDA cleared for applications in dermatology, plastic surgery, and podiatry in the United States. John Strisower, CEO of PathoLase, noted that he is confident the device will be made available to licensed Canadian medical practitioners after the Health Canada review process is completed. Stated Strisower: "Onychomycosis afflicts approximately 900 million people around the world, including millions in Canada. We"re very much looking forward to making PinPointe FootLaser available to Canadian practitioners as well, offering them an excellent opportunity for providing a unique and valuable service to their patients." Safe Quick Treatment - No Drugs, Pain or Anesthesia Introduced in 2008, PinPointe FootLaser uses a patented laser technology to target the pathogens that cause toenail fungus. With PinPointe FootLaser, patients are treated safely and quickly with no drugs, no anesthesia and no pain. PinPointe"s laser light passes through the toenail without causing damage to the nail or surrounding skin. Following the procedure, the new nail will grow in healthy and clear. Unlike medication-driven treatments for toenail fungus, PinPointe FootLaser presents minimal risk of side effects. Competing medication procedures can result in a wide variety of side effects, including liver toxicity. New Clinical Trial Currently Underway Following an early study conducted among a small group of patients (Harris, McDowell and Strisower, Laser Treatment for Toenail Fungus, Proc. SPIE 7161A, 2009), which indicated a potential efficacy rate as high as 87%, the treatment is currently undergoing a major multi-site clinical trial entitled "Multi-Center Trial: Evaluation of PinPointe FootLaser Treatment for Infected Toenails (Onychomycosis)". The study, which has been granted approval by Health Canada, is being conducted at the dermatology clinic and research facility of Aditya K. Gupta, M.D., Ph.D., M.A. (Cantab), DABD, FAAD, FRCPC in London, Ontario, as well as at three additional sites in the U.S. About PinPointe FootLaser PinPointe™ FootLaser™ is a groundbreaking laser treatment for toenail fungus that was launched in September 2008 by Chico, CA-based PathoLase, Inc. PinPointe FootLaser targets the pathogens that cause toenail fungus (Onychomycosis), an infection that afflicts an estimated 40 million people in the U.S. alone. PinPointe FootLaser recently received the first and only medical device clearance for toenail fungus treatment in Europe (CE Mark). For more information please visit http://www.pinpointefootlaser.com. PathoLase, Inc.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009